On the contrary, in our study on colon cancer, strong KIAA1199 expression was generally not significantly correlated to lower overall survival or the development of liver or lung metastases in patients with stage II primary tumours (patients developing peritoneal dissemination were excluded from our analyses). The gene discussed is CEMIP; the disease is malignant colon neoplasm.